← Back to headlines
Alvotech Shares Rise on FDA Acceptance of Entyvio Biosimilar Application
Alvotech shares jumped after the U.S. Food and Drug Administration (FDA) accepted its Biologics License Application (BLA) for a biosimilar to Entyvio for review. This development marks a significant step for Alvotech in bringing its biosimilar to market.
8 Jun, 08:29 — 8 Jun, 10:41
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Coverage Timeline
First report: seeking-alpha · 8 Jun, 08:29|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
